Bone Biologics Corporation (BBLGW) Operating margin 2016–2020
Bone Biologics Corporation (BBLGW) operating margin by fiscal year — reported operating income divided by reported revenue.
-0.1%FY2020 · since FY2016: -1.9% → -0.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -0.1% | +0.2 pp |
| FY2019 | -0.2% | — |
| FY2016 | -1.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BBLGW financial trends
BBLGW RevenueBBLGW Net incomeBBLGW Net marginBBLGW Gross profitBBLGW Gross marginBBLGW Operating incomeBBLGW Operating cash flowBBLGW Free cash flowBBLGW Capital expendituresBBLGW Return on equityBBLGW Stock buybacksBBLGW Dividends paidBBLGW Total assetsBBLGW Total liabilitiesBBLGW Shareholders’ equityBBLGW overview →